verified SJR 0,78 · Q2

United States · Mary Ann Liebert Inc.

workspace_premium Q2 — Genetics lock Subscription

Human gene therapy methods

Human gene therapy methods is a journal indexed in SJR in Genetics and Pharmacology with an H index of 35. It has an SJR impact factor of 0,78 and it has a best quartile of Q2. It has an SJR impact factor of 0,78.

ISSN: 1946-6536

Publisher: Mary Ann Liebert Inc.

Category: Genetics

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,78 Q2

H-index 35

Acceptance rate pie_chart

35%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

0,78

H-index

Docs (year)

Docs 3y

Total refs

Cites 3y

Citable 3y

Cites/Doc 2y

Ref/Doc

0.0

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

AAV2/8 Vectors Purified from Culture Medium with a Simple and Rapid Protocol Transduce Murine Liver, Muscle, and Retina Efficiently

Using Pulmozyme DNase Treatment in Lentiviral Vector Production

Concurrent Measures of Fusion and Transduction Efficiency of Primary CD34+ Cells with Human Immunodeficiency Virus 1-Based Lentiviral Vectors Reveal Different Effects of Transduction Enhancers

Comparison of Adeno-Associated Virus Serotypes and Delivery Methods for Cardiac Gene Transfer

Chromatography Purification of Canine Adenoviral Vectors

Characterization of Lentiviral Vector Production Using Microwell Suspension Cultures of HEK293T-Derived Producer Cells

Anti-Dystrophin T Cell Responses in Duchenne Muscular Dystrophy: Prevalence and a Glucocorticoid Treatment Effect

Analytical Ultracentrifugation as an Approach to Characterize Recombinant Adeno-Associated Viral Vectors

An Independent Construct for Conditional Expression of Atonal Homolog-1

Adenovirus Particle Quantification in Cell Lysates Using Light Scattering

Adeno-Associated Virus-Mediated Overexpression of LARGE Rescues a-Dystroglycan Function in Dystrophic Mice with Mutations in the Fukutin-Related Protein

Adeno-Associated Virus Enhances Wild-Type and Oncolytic Adenovirus Spread

SHOW MORE ARTICLES

Accurate and Rapid Sequence Analysis of Adeno-Associated Virus Plasmids by Illumina Next-Generation Sequencing

(RT)-qPCR for detection of and differentiation between RNA and DNA of HIV-1-based lentiviral vectors

AAV-8 Is More Efficient than AAV-9 in Transducing Neonatal Dog Heart

A Systematic Approach to the Establishment and Characterization of Endothelial Progenitor Cells for Gene Therapy

A Simple and Effective Method to Generate Lentiviral Vectors for Ex Vivo Gene Delivery to Mature Human Peripheral Blood Lymphocytes

A Short and Efficient Transduction Protocol for Mouse Hematopoietic Stem Cells with Lentiviral Vectors

A Quantitative Chloride Channel Conductance Assay for Efficacy Testing of AAV.BEST1

A Novel Method for the Quantification of Adeno-Associated Virus Vectors for RNA Interference Applications Using Quantitative Polymerase Chain Reaction and Purified Genomic Adeno-Associated Virus DNA as a Standard

A New Method for Generating Insulin-Secreting Cells from Human Pancreatic Epithelial Cells After Islet Isolation Transformed by NeuroD1

A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies

A Capillary Electrophoresis Sequencing Method for the Identification of Mutations in the Inverted Terminal Repeats of Adeno-Associated Virus

A Call to Arms for Improved Vector Analytics!

FAQs

Human gene therapy methods has an SJR of 0,78 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Human gene therapy methods is 35%.

Human gene therapy methods

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Human gene therapy methods?

What is the APC / publication cost?

What is the acceptance rate?